These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3793161)

  • 1. Ranitidine in the management of gastric ulcer.
    Colin-Jones DG
    Indian J Gastroenterol; 1986 Oct; 5 Suppl():15-6. PubMed ID: 3793161
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose ranitidine for the prevention of recurrent peptic ulcer disease in rheumatoid arthritis patients taking NSAIDs.
    ten Wolde S; Dijkmans BA; Janssen M; Hermans J; Lamers CB
    Aliment Pharmacol Ther; 1996 Jun; 10(3):347-51. PubMed ID: 8791962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranitidine in children with peptic ulcer and patients with pancreatic cystic fibrosis.
    Scorza A; Conti-Nibali S; Sferlazzas C; Saitta G; Tedeschi A
    Int J Clin Pharmacol Res; 1990; 10(3):179-82. PubMed ID: 2228343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of acid-related diseases of the gastrointestinal tract. Observations in patients receiving a single evening dose of 300 mg ranitidine].
    Sewing KF; Franz E
    Fortschr Med; 1992 Mar; 110(7):114-6. PubMed ID: 1559647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; intermittent and long-term administration].
    Sakai H; Oka H; Sakaguchi M
    Nihon Rinsho; 1988 Jan; 46(1):114-8. PubMed ID: 2897481
    [No Abstract]   [Full Text] [Related]  

  • 6. Ulcer healing and relapse prevention by ranitidine in peptic ulcer disease.
    Liedberg G; Davies HJ; Enskog L; Eriksson S; Frederiksen B; Graffner H; Hradsky M; Oscarson J; Rydberg B; Simert G
    Scand J Gastroenterol; 1985 Oct; 20(8):941-4. PubMed ID: 3909374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term treatment of peptic ulcer with histamine H2 receptor blockaders: results of their use and new problems].
    Grigor'ev PIa; Isakov VA
    Klin Med (Mosk); 1991 Oct; 69(10):93-7. PubMed ID: 1685004
    [No Abstract]   [Full Text] [Related]  

  • 8. The magnitude of nocturnal acid suppression by ranitidine 300 mg given at 18.00 hours.
    Ovartlarnporn B; Prichaworawach S; Niyomthai N; Wuthi S; Chamsai M; Tansakool U
    J Med Assoc Thai; 1992 Feb; 75(2):110-5. PubMed ID: 1645048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of peptic ulcer maintenance trials.
    Robinson M
    Am J Med; 1984 Nov; 77(5B):23-9. PubMed ID: 6095657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nizatidine versus ranitidine in the treatment of peptic ulcer disease: report on the Dutch investigation as part of a European multicentre trial.
    Kuipers EJ; Hazenberg HJ; Quik RF; Hazenberg BP; de Zwart PA
    Neth J Med; 1990 Aug; 37(1-2):58-62. PubMed ID: 1977089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical use of histamine-2 receptor antagonists.
    Michocki RJ; Richardson JP
    Md Med J; 1992 May; 41(5):397-400. PubMed ID: 1625532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of cimetidine and ranitidine in peptic ulcer].
    Grigor'ev PIa; Kharkovskiĭ NN; Iakovenko EP; Prianishnikova AS; Soluianova IP
    Sov Med; 1986; (3):94-8. PubMed ID: 3520869
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative evaluation of cimetidine and ranitidine.
    Zimmerman TW; Schenker S
    Ration Drug Ther; 1985 Apr; 19(4):1-7. PubMed ID: 2932770
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of ranitidine in gastroduodenal ulcer].
    Buligescu L; Milcu V; Voiculescu M; Sava C; Popescu A; Dumitrescu D; Stefănescu D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(4):357-60. PubMed ID: 2865797
    [No Abstract]   [Full Text] [Related]  

  • 15. Review of ulcer treatment: role of ranitidine.
    Boyd EJ; Wilson JA; Wormsley KG
    J Clin Gastroenterol; 1983; 5 Suppl 1():133-41. PubMed ID: 6317738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of different antibiotic regimens for eradication treatment of Helicobacter pylori infection in peptic ulcer disease in Tanzanian patients.
    Neuhann HF; Swai B; Carpenter CF; Shao O
    Trop Doct; 2003 Oct; 33(4):225-8. PubMed ID: 14620428
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of peptic ulcer with i.v. ranitidine. A treatment possibility in special cases. Experiences from general practice].
    Kemmer R; Taenzer HJ
    Fortschr Med; 1984 Feb; 102(8):201-2. PubMed ID: 6086476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
    Graham DY; Hepps KS; Ramirez FC; Lew GM; Saeed ZA
    Scand J Gastroenterol; 1993 Nov; 28(11):939-42. PubMed ID: 8284627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranitidine bismuth citrate plus azithromycin for Helicobacter pylori eradication.
    Bujanda L; Muñoz C; Sánchez A; Iriondo C; Cosme A
    J Clin Gastroenterol; 2000 Apr; 30(3):337-8. PubMed ID: 10777206
    [No Abstract]   [Full Text] [Related]  

  • 20. Seasonal treatment with ranitidine.
    Palmas F; Andriulli A; Verme G
    Lancet; 1984 Sep; 2(8404):698-9. PubMed ID: 6147724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.